ATAD2 levels are low or absent in healthy somatic cells, but ATAD2 is upregulated in diverse cancer types, wherein high ATAD2 expression is associated with a high histological grade, high rates of metastasis and recurrence, and poor overall survival [84,85]. Here, ATAD2 is linked to cancer.